首页> 外文会议>ACM international health informatics symposium;IHI'10 >Novel Biological Network Features Discovery for In Silico Identification of Drug Targets
【24h】

Novel Biological Network Features Discovery for In Silico Identification of Drug Targets

机译:新型生物网络功能的发现,用于计算机识别药物靶标

获取原文

摘要

In silico identification of potential drug targets is a crucial task for drug discovery. Traditional approaches utilize only protein sequence or structural information to predict drug targets, and achieve limited successes. Since cellular proteins function in the context of interaction networks by interacting with other cellular macromolecules, analysis of topological features of proteins in such networks reveal important insights on the potential druggability of proteins. In this paper, we first introduced ten novel topological features extracted from the human protein-protein interaction network. When designing these new features, we specially emphasized the roles of three disease-related groups of proteins: known drug targets, disease genes, and essential genes. Based on these novel network features, we built highly accurate models with up to 80% classification accuracy using support vector machines, Ll-regularized logistic regression, and k-nearest neighbors to predict drug target, and analyzed the relevance of each feature to the proteins' druggability. Moreover, we combined our network features with a set of protein sequence features, and achieved more robust experimental performance. With the framework of integrating both network and sequence features, our method can also be used to prioritize multiple candidate proteins according to their predicted druggability.
机译:在计算机上识别潜在的药物靶标是发现药物的关键任务。传统方法仅利用蛋白质序列或结构信息来预测药物靶标,并获得有限的成功。由于细胞蛋白通过与其他细胞大分子相互作用而在相互作用网络中发挥作用,因此对此类网络中蛋白质拓扑特征的分析揭示了对蛋白质潜在药物作用的重要见解。在本文中,我们首先介绍了从人蛋白质-蛋白质相互作用网络中提取的十种新颖的拓扑特征。在设计这些新功能时,我们特别强调了三种与疾病相关的蛋白质的作用:已知的药物靶标,疾病基因和必需基因。基于这些新颖的网络特征,我们使用支持向量机,Ll正规对数回归和k最近邻来预测药物靶标,从而建立了分类精度高达80%的高精度模型,并分析了每个特征与蛋白质的相关性可药用性。此外,我们将网络功能与一组蛋白质序列功能相结合,并获得了更强大的实验性能。通过整合网络和序列特征的框架,我们的方法还可以用于根据预测的药物可塑性对多种候选蛋白进行优先排序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号